AWARDDEFINITIVE CONTRACTSmall business
Definitive contract W911QY20C0100MODERNATX, INC.
Overview
Award facts
- Net obligations
- $8.20B
- $8,204,906,278of $8.20B potential value
- Period of performance
- Aug 11, 2020 to Aug 10, 2023
- Ended
- Modifications
- 32
- Latest action Sep 22, 2023
- Contract type
- Definitive contract
- PIID W911QY20C0100
Description of requirement
100M SARS-COV-2 MRNA-1273 VACCINE DOSES
Dates and value
- Award date
- Signed on Aug 11, 2020
- Potential end of performance
- Aug 9, 2023
- Current value
- $8,204,906,278Base and exercised options
- Potential value (if all options are exercised)
- $8,204,906,278
Obligations by fiscal year of action
- FY2023: $287,655
- FY2022: $59,026,961
- FY2021: $6,920,591,663
- FY2020: $1,225,000,000
Total across 4 fiscal years: $8,204,906,278
The Department of Defense funded and awarded this contract. DoD contract actions are withheld at the source for about 90 days after signature, so actions signed after Aug 20, 2026 are not yet public.
Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Sep 22, 2023. View on USAspending · Recipient on SAM.gov
Recipient
NameMODERNATX, INC.
LocationCAMBRIDGE, MA
UEIWJYNZ8AK2D47
CAGE code6RP85
Business sizeSmall businessSize at award, per the contracting officer
Organization typeCorporate not tax exempt
Parent companyMODERNATX INC.
Business types and certifications
For-profit organizationCorporation (not tax-exempt)
As represented in SAM.gov at the time of the action.
Subcontracting network
The prime, the subcontractors on this award, and their own subcontractors.
Agency and place
Awarding and funding
- Awarded by
- Department of Defense
- Department Of The Army
- W6QK ACC-APG NATICK
- Funded by
- Department of Defense
- Department Of The Army
- W6DZ JPMO CBD JPMO MCS (06)
- Funded from
- Basic research; Field is optional prior to fy21Program activities021-2040Federal accounts (agency financial reports)
Place of performance
- Place of performance
- Cambridge, Middlesex County, Massachusetts 02139-3578
- Congressional district (place of performance)
- MA-07As reported at the time of the action
Classification and competition
Classification
- Product or service (PSC)
- 6505DRUGS AND BIOLOGICALS (product)
Competition
- Extent competed
- Not competedC
- Reason not competed
- Urgency (FAR 6.302-2)URG
- Solicitation procedures
- Only one sourceSSS
- Set-aside
- No set-aside used
- Contract pricing
- Firm fixed priceJ
- Offers received
- 1
Solicitation and notices
- Solicitation ID
- W911QY20R0043(as reported)
- Solicitation date
- Jul 1, 2020
Contract details
- Subcontracting plan
- Plan not requiredB
- Cost Accounting Standards clause
- Not applicable exempt from CASX
- Certified cost or pricing data
- Yes
- Contract financing
- Performance-based financingF
- Service Contract Act labor standards
- No
- Commercial procedures
- Commercial products/servicesA
- Government-furnished property
- Transaction does not use GFE/GFPN
- Bundled requirement
- Not bundledH
- Consolidated requirement
- Not consolidatedD
- Undefinitized action (terms not final)
- Other undefinitized actionB
- Multi-year contract
- Yes
Linked notices
Notice | Notice ID | Type | Link | Posted |
|---|---|---|---|---|
Transaction history
Modification history
- Base award
- Aug 11, 2020Base obligation at award: $1,225,000,000
- Latest action
- Sep 22, 2023 — Funding onlyModification P00031; obligation change -$220,345; funding only: changes obligations, not scope
- Latest substantive action
- May 1, 2023 — Supplemental agreement (within scope)Modification P00029; obligation change +$508,000
- Latest funding action
- Sep 22, 2023 — Funding onlyModification P00031; obligation change -$220,345; funding only: changes obligations, not scope
- Actions by type
- Base award1
- Other administrative action22
- Supplemental agreement (within scope)3
- Option exercised3
- Change order2
- Funding only1
- Change order definitized1
Similar awards
PIID | Match | Awardee |
|---|---|---|
All contract data
All contract data
Every other field reported for this award, as of its latest reported action
Competition
- Evaluation preference
- No preference used
- Local area set-aside
- No
- Simplified procedures for commercial items
- No
- A-76 (FAIR Act) action
- No
Pricing and financing
- Paid by purchase card
- No
- Latest action: change in base and exercised options
- -$220,345
- Latest action: change in base and all options
- -$220,345
Socio-economic and policy
- Recovered materials and sustainability
- No clauses included and no sustainability includedC
- EPA-designated product
- Meets requirementsA
- Clinger-Cohen Act planning (IT)
- No
- Walsh-Healey Act (materials and supplies)
- No
- Construction wage rates (Davis-Bacon)
- No
Place and origin
- Domestic or foreign entity
- U.S. owned businessA
- Country of product or service origin
- United statesUSA
- Place of manufacture
- Mfg in U.S.D
- Sea transportation
- No
Structure
- Award or IDV
- Award
- Award type
- Definitive contractD
- IT commercial item category
- Not IT products or servicesZ
- DoD claimant program
- Medical and dental supplies and equipmentC9B
- Awarding agency code
- 9700
- Awarding sub-tier code
- 2100
- Contracting office code
- W58P05
- Transactions recorded under this award key
- 33
Funding
- Funding agency code
- 9700
- Funding sub-tier code
- 2100
- Funding office code
- W56XNH
- Treasury accounts
- 021-2020/2021-2040-000
- 021-2021/2022-2040-000
- Object classes
- 25.5: Research and development contracts
- Disaster or emergency funding (DEFC)
- N: Emergency P.L. 116-136
- Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression
- COVID-19 supplemental obligations
- $2,450,000,000